Wednesday, January 20, 2021
Home Tags Vaccines

Vaccines Related News

UK vaccinates four million people against COVID-19

UK vaccinates four million people against COVID-19

More than four million people have received their first dose of the COVID-19 vaccines, with more than half of those over 80 receiving a...
A united approach to fighting COVID-19 in Europe

A united approach to fighting COVID-19 in Europe

The European Commission has set out several actions to be taken across Europe to establish a united front in beating the COVID-19 virus. The European...
Fast-tracking the use of copper in the NHS to tackle AMR

Fast-tracking the use of copper in the NHS to tackle AMR

Rory Donnelly, clinical research director of Copper Clothing, discusses the need to fast track copper for use in the NHS as an antimicrobial material...
WHO emergency committee advises on new COVID-19 variants

WHO emergency committee advises on new COVID-19 variants

The WHO Emergency Committee on COVID-19 met to review and advise on the new variants of COVID-19. The committee met at the request of WHO...
First global resolution on meningitis prevention and control

First global resolution on meningitis prevention and control

A global roadmap to defeat meningitis by 2030 has been established under the leadership of the World Health Organization. At the 73rd Session of the...
Global Ebola vaccine stockpile now established

Global Ebola vaccine stockpile now established

A global stockpile of Ebola vaccines has now been established by four of the leading health and humanitarian organisations. Led by the International Coordinating Group...
Moderna COVID-19 vaccine receives approval in UK

Moderna COVID-19 vaccine receives approval in UK

The British Government has now authorised the Moderna COVID-19 vaccine for use. The Moderna COVID-19 vaccine has become the third in Britain to gain authorisation...
Pfizer-BioNTech vaccine shows protection against new COVID-19 strains

Pfizer-BioNTech vaccine shows protection against new COVID-19 strains

Results from a new study have shown that the Pfizer/BioNTech vaccine shows protection against two new mutant strains of coronavirus. In an in vitro study...
COVID-19 immunity could last eight months, says research

COVID-19 immunity could last eight months, says research

New research has suggested that immunity to COVID-19 could last for up to eight months following infection. The findings, which were based on blood samples...
World first COVID-19 smart vaccine patch

World first COVID-19 smart vaccine patch

In a world first development, researchers are creating a COVID-19 smart vaccine patch that will deliver the vaccine as well as measure its efficacy. The...
Second COVID-19 vaccine authorised by the European Commission

Second COVID-19 vaccine authorised by the European Commission

The European Commission has granted conditional marketing authorisation (CMA) for the Moderna COVID-19 vaccine – the second one to be authorised in the EU. The...
WHO lists Pfizer/BioNTech COVID-19 vaccine for emergency use

WHO lists Pfizer/BioNTech COVID-19 vaccine for emergency use

As more countries across the globe begin rolling out their mass COVID-19 vaccination programmes, the World Health Organization (WHO) has now listed the Pfizer/BioNTech...
NHS needs more resources to vaccinate public effectively warns BMA

NHS needs more resources to vaccinate public effectively warns BMA

The BMA has warned the NHS will need more resources if it is to vaccinate the public effectively after a new survey has revealed...
Oxford University COVID-19 vaccine roll out begins

Oxford University COVID-19 vaccine roll out begins

The first person in the UK has now received the Oxford University and AstraZeneca COVID-19 vaccine, which has begun its NHS roll out today. The...
European Commission concludes Novavax talks for COVID-19 vaccine

European Commission concludes Novavax talks for COVID-19 vaccine

The European Commission has concluded its talks with pharmaceutical company Novavax regarding the purchase of its potential COVID-19 vaccine. The European Commission and Novavax envisaged...
Clinical trials for another COVID-19 vaccine begin in UK

Clinical trials for another COVID-19 vaccine begin in UK

Early Phase I and Phase II clinical trials have started in the UK for the Valneva COVID-19 vaccine, which is to be tested on...
Can vaccines truly bring COVID-19 under control?

Can vaccines truly bring COVID-19 under control?

In order to truly bring COVID-19 under control, vaccines must prevent infection, disease progression, and transmission, say experts. In a new editorial published in the...
COVID-19 Oxford vaccine found safe and effective in Phase III trial

COVID-19 Oxford vaccine found safe and effective in Phase III trial

The first full results from the Phase III Oxford COVID-19 vaccine have found it to be safe and effective to protect against the virus. The...
Meningococcus B vaccine shows 79% effectiveness

Meningococcus B vaccine shows 79% effectiveness

A vaccine for the deadly Meningococcus B has been shown to have 79% effectiveness in patients under the age of 18. Meningococcus group B is...
Over half a million Brits participating in COVID-19 research

Over half a million Brits participating in COVID-19 research

Over half a million British people have taken part in pioneering health research into COVID-19 over the last eight months. The UK has been conducting...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest